Home › Research › Disparities
The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease
Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, Ngai C, Tycko B et al.. Annals of neurology, 1993-11-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Apolipoprotein E (APO-E) binds to the beta-amyloid peptide and is present in senile neuritic plaques in Alzheimer's disease (AD). The epsilon 4 isoform of APO-E has been associated with both sporadic and familial late-onset AD, implying a causal role. Among patients and control subjects similar in age, gender, and ethnic group from the New York City community of Washington Heights-Inwood, we found that the odds ratio (OR) for AD associated with homozygosity for APO-epsilon 4 was 17.9 (95% confidence interval [CI], 4.6-69.8) and that associated with heterozygosity for APO-epsilon 4 was 4.2 (95% CI, 1.8-9.5) compared with persons with other APO-E genotypes. The association was stronger among patients with sporadic disease (OR = 10.3; 95% CI, 3.4-31.1) than among those with a family history of dementia in a first-degree relative (OR = 0.9; 95% CI, 0.1-13.5). The association between APO-epsilon 4 and AD did not differ according to age at onset ( or = 65), but appeared to vary across the 3 ethnic groups investigated (black, Hispanic, and white). Our data confirm the association between AD and APO-epsilon 4 and support the hypothesis that the APO-epsilon 4 allele either confers genetic susceptibility to AD or may be in linkage disequilibrium with another susceptibility locus. Ethnic variability in the allelic frequency of APO-epsilon 4 in the elderly warrants further investigation.
What this study adds
Evidence grade: Low
This 1993 study compared people with Alzheimer's and matched controls from the Washington Heights-Inwood community of New York City (Black, Hispanic and white residents). Reported effect size: OR = 10.3; OR = 0.9.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tang, M. X., Maestre, G., et al. (1993). The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Annals of neurology. https://doi.org/10.1002/ana.410340527
Vancouver
Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, et al. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Annals of neurology. 1993. doi:10.1002/ana.410340527. PMID: 8239575.
BibTeX
@article{mayeux1993-8239575,
author = {Mayeux, R. and Stern, Y. and Ottman, R. and Tatemichi, T. K. and Tang, M. X. and Maestre, G. and Ngai, C. and Tycko, B. and others},
title = {{The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease}},
journal = {Annals of neurology},
year = {1993},
doi = {10.1002/ana.410340527},
pmid = {8239575},
url = {https://doi.org/10.1002/ana.410340527}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The epsilon 4 isoform of APO-E has been associated with both sporadic and familial late-onset AD, implying a causal role.
- Among patients and control subjects similar in age, gender, and ethnic group from the New York City community of Washington Heights-Inwood, we found that the odds ratio (OR) for AD associated with homozygosity for APO-epsilon 4 was 17.9 (95% confidence interval [CI], 4.6-69.8) and that associated with heterozygosity for APO-epsilon 4 was 4.2 (95% CI, 1.8-9.5) compared with persons with other APO-E genotypes.
Why it matters
This 1993 study compared people with Alzheimer's and matched controls from the Washington Heights-Inwood community of New York City (Black, Hispanic and white residents). Patients were more likely than controls to carry the APOE ε4 gene variant, with an odds ratio of 4.2 for one copy and 17.9 (range 4.6–69.8) for two copies; the link was clear in people without a family history of dementia, while the estimate for those with one was too imprecise to judge, and the authors say the link "appeared to vary" by ethnic group. This shows an association, not proof of cause, since the authors allow that a nearby gene may be responsible, and it does not tell any individual their chance of developing Alzheimer's.
New to this subject? Start with our plain-English guide: Disparities →
Study details
- Effect sizeOR = 10.3; OR = 0.9
- Evidence strengthLow
How this study scored 55/100
Published in a leading specialty journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Annals of neurology) |
| Journal's citation record | 3 / 4 | Annals of Neurology: journal h-index 437 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1993 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 414 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 11.8 citations a year over 35 year(s) since 1993 |
| Impact for its field and year | 5 / 6 | Cited 31.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 35 other studies in this library |
| Still being cited | 1 / 4 | Cited 12 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Henry N. Ginsberg: h-index 107 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Columbia University: institution h-index 1,824 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8239575) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
35 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Disparities from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.